Background Identifying modifiable factors that increase women's vulnerability to HIV is a
critical step in developing effective female-initiated prevention interventions. The primary …

Introduction Adolescent girls and young women (AGYW) in Africa have high HIV incidence
despite scale‐up of HIV testing and HIV treatment. Placebo‐controlled trials of tenofovir …

Adherence is a critical component of the success of antiretroviral-based pre-exposure
prophylaxis (PrEP) in averting new HIV-infections. Ensuring drug availability at the time of …

Background Reproductive-age women need effective interventions to prevent the
acquisition of human immunodeficiency virus type 1 (HIV-1) infection. Methods We …

Background Antiretroviral medications that are used as prophylaxis can prevent acquisition
of human immunodeficiency virus type 1 (HIV-1) infection. However, in clinical trials among …

Objective: To explore the relationship between early age of coital debut (15 years of age or
younger) and risk for HIV infection among sexually active urbanized Zimbabwean women …

This paper examines the association between social networks and contraceptive use. Using
data from a survey of women belonging to voluntary associations in Yaoundé, Cameroon …

Although the balance of recent evidence supports the efficacy of antiretroviral (ARV)-based
pre-exposure prophylaxis (PrEP) against HIV-1 infection, recent negative trial results are …

Background Female-controlled methods of HIV prevention are urgently needed. We
assessed the effect of provision of latex diaphragm, lubricant gel, and condoms …

Background In VOICE, a multisite HIV pre-exposure prophylaxis (PrEP) trial, plasma drug
levels pointed to widespread product nonuse, despite high adherence estimated by self …